1Garaci E,Pica F,Sinibaldi- Vallebona P,et al. Thymosinal in combination with cytokines and chemotherapy for the treatment of cancer[J]. Int Immunopharmacol,2003,3(8): 1145 - 1150
4Shuqun C,Mengchao W, Han C, et al. Combination transcatheter hepatic arterial chemoembolization with thymosin alpha 1 on recurrence prevention of hepatocellular carcinoma [J]. Hepatogastroenterology,2004,51(59):1445- 1447
5Degli- Esposti MA, Smyth MJ. Close encounters of different kinds:dendritic cells and NK cells take centre stage[J], Nature Rev Immunol,2005,5(2):112- 124
8Sugahara S, Ichida T, Yamagiwa S, et al. Thymosin- alpha 1 increases intrahepatic NKT ceils and CTLs in patients with chronic hepatitis B[J]. Hepatol Res,2002,24(4):346-354
1HUANG Zi—cun,YANG Jian,ZHOU Jian—liang,et al(黄自存,杨健,周建良,等).Thymosin al modulate the immunity of Severe hepatitis[J].Clinical Hepatobiliary Journal(临床肝胆杂志),2000,16(2):97—99.(in Chinese).
2SHI Ting—zhang,DAI Guang—hai(石廷章,戴广海).The reporte of clinical studying on I stage malignant tumor patients accepted IL-2 treatment[J].Chinese Tumor Clinical(中国肿瘤临床),1999,26(4):314—317.(in Chinese).
3Francesco P,Pica F, Fmarini S,et al. Thymosin alpha one restore murune T-cell-mediated responses inhibited by in vivo cocaine adminitration [J]. Int J Immunophar-macoi,1992,14(91):18--22.
4Pica F, Fraschett M, Matteucci C,et al. High dose of thymosin alpha 1 enhance the anti-tumor efficacy of combination. Chemo-immunotherapy for murine B16 melanoma [J]. Anticancer Res, 1998, 18 (5): 3571 --3576.
5Eckert K,Schmitt M,Garbin F,et al. Thymosin alpha 1 effects, in vitro, on lymphokine-activated killer cells from patients with primary immunodeficiencies:preliminary results [J]. Int Immunopharmacol, 1994,16(12) :1019--1023.
6GAO Zhong—du,YUAN Wei—xiang,MAO Ai—wu,et al(高中度,袁维祥,茅爱武,等).Thymosin αl influence T lymphocyte.Subsets of malignant tumor patients accepted intervene chemotherapy[J].Clinical Medicine(临床医学),2000,20(7):8—9.(in Chinese).
7LU Jian—wei,ZHOU Zhen—ying,CHEN Jia,et al(陆建伟,周振英,陈嘉,等).The immunity of inalignant tumor patient accepted chemotherapyis enfluenced by Thymosin α1[J].Chinese New Medicine Journal(中国新药杂志),1999,8(12):834—836.(in Chinese).
8WU Zhen—feng,WANG Tie—jun,CHI Jing—xin,et al(吴镇凤,王铁君,迟景新,等).Large dose of thymosin α1 enfluence the T hymphocyte subsets of tumor patients accepted radiotherapy[J].Chinese Journal of Immunity(中国免疫杂志),1998,14(6):438—439.(in Chinese).
9Garaci E,Pica F,Sinibaldi-Vallebona p,et al. T Thymosin alpha(1 ) in combination with cytokines and chemotherapy for the treatment of cancer[J]. Int Immunopharmacol, 2003, 3 (8): 1145-1150.
6Takeuchi H,Maehara Y,Tokunaga E. Prognostic significance of natural killer cell activity in patients with gastric carcinoma:a multivariate analysis[J].American Journal of Gastroenterology,2001,(12):574-578.
7Hasholzner U,Stieber P,Reiter W,et a1. CA242 in comparison with established tumor markers in colorectal,pancreatic and lung cancer[J].Anticancer Research,1999,(02):2477.
